Aidan Quinn
About Aidan Quinn
Aidan Quinn is a Postdoctoral Scholar currently working at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute, focusing on cancer biology, particularly tumorigenesis, chemotherapy response, and immune therapy. He holds a Ph.D. in Pathobiology and Mechanisms of Human Disease from Columbia University and has a background in clinical informatics and research.
Work at Broad Institute
Aidan Quinn has been serving as a Postdoctoral Scholar at the Broad Institute of MIT and Harvard since 2022. This role is based in Cambridge, Massachusetts, where he focuses on cancer biology. His work involves integrating genetics and systems biology to understand various aspects of tumorigenesis and chemotherapy response.
Current Position at Dana-Farber Cancer Institute
In addition to his role at the Broad Institute, Aidan Quinn is also a Postdoctoral Researcher at the Dana-Farber Cancer Institute, starting in 2022. Located in Boston, Massachusetts, his research here aligns with his interests in immune therapy and cancer biology, contributing to the institute's mission in cancer research.
Previous Experience at Columbia University
Before his current positions, Aidan Quinn worked at Columbia University Irving Medical Center as a Postdoctoral Research Fellow from 2021 to 2022. His prior experience also includes roles as a Research Assistant at Columbia University Institute for Cancer Genetics and as a Volunteer Research Assistant at Columbia University Medical Center.
Educational Background
Aidan Quinn has an extensive educational background in the life sciences. He earned a Doctor of Philosophy (Ph.D.) in Pathobiology and Mechanisms of Human Disease from Columbia University. He also holds a Master of Arts in Biotechnology from Columbia University and a Bachelor of Science in Psychology from Fairfield University. Additionally, he participated in a Summer Program in Human Physiology at Georgetown University School of Medicine.
Research Interests and Future Goals
Aidan Quinn's research interests center on tumorigenesis, chemotherapy response, and immune therapy within cancer biology. He aims to establish a dedicated laboratory focused on investigating these areas further, contributing to advancements in cancer research and treatment methodologies.